Journals / Turkish Journal of Biology / 2021 / Cilt: 45 - Sayı: 2

Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer

Pages
127–137
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to literature searching, GATA2 and TORYAIP1 might represent potential biomarkers and candidate drug targets for thestroma targeted cancer therapy applications

📌 3 Key Takeaways

🎯
Objective & Hypothesis:: Tumor stroma interaction is known to take a crucial role in cancer growth and progression.
📊
Key Findings & Data:The integrative analyses of DEGs indicatedthat there were 59 common core genes, which might be feasible to be potential marks for cancer stroma targeted strategies.
💡
Conclusion & Impact:According to literature searching, GATA2 and TORYAIP1 might represent potential biomarkers and candidate drug targets for thestroma targeted cancer therapy applications
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

: Tumor stroma interaction is known to take a crucial role in cancer growth and progression. In the present study, it was performed gene expression analysis of stroma samples with ovarian and breast cancer through an integrative analysis framework to identifycommon critical biomolecules at multiomics levels. Gene expression datasets were statistically analyzed to identify common differentially expressed genes (DEGs) by comparing tumor stroma and normal stroma samples. The integrative analyses of DEGs indicatedthat there were 59 common core genes, which might be feasible to be potential marks for cancer stroma targeted strategies. Reportermolecules (i.e. receptor, transcription factors and miRNAs) were determined through a statistical test employing the hypergeometricprobability density function. Afterward, the tumor microenvironment protein-protein interaction and the generic network were reconstructed by using identified reporter molecules and common core DEGs. Through a systems medicine approach, it was determined thathub biomolecules, AR, GATA2, miR-124, TOR1AIP1, ESR1, EGFR, STAT1, miR-192, GATA3, COL1A1, in tumor microenvironmentgeneric network. These molecules were also identified as prognostic signatures in breast and ovarian tumor samples via survival analysis. According to literature searching, GATA2 and TORYAIP1 might represent potential biomarkers and candidate drug targets for thestroma targeted cancer therapy applications

🔖

Cite This Article

GÖV, E., ERCEYLAN, Ö. F., SAVAŞ, A. (2022). Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer. Turkish Journal of Biology, Cilt: 45 - Sayı: 2, 127–137. https://ajindex.com/articles/600105

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Agostini A, Brunetti M, Davidson B, Tropé CG, Eriksson AGZ et al. (2018). The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas. Scientific Reports 8 (1): 1-7. doi: 10.1038/s41598-018-29332-7
  2. Aguirre-Gamboa R, Gomez-Rueda H, Martínez-Ledesma E, Martínez-Torteya A, Chacolla-Huaringa R et al. (2013). SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS One 168 (9): e74250. doi: 10.1371/journal.pone.0074250 Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF et al. (2013). NCBI GEO: Archive for functional genomics data sets - update. Nucleic Acids Research 41 (D1): 991-995. doi: 10.1093/ nar/gks1193 Bhargava R, Gerald WL, Li AR, Pan Q, Lal P et al. (2005). EGFR gene amplification in breast cancer: Correlation with epidermal growth factor receptor mRNA and protein expression and HER2 status and absence of EGFR-activating mutations. Modern Pathology 18 (8): 1027-1033. doi: 10.1038/modpathol.3800438 Bhowmick NA, Moses HL (2005). Tumor stroma interactions. Current Opinion in Genetics & Development 15 (1): 1-8. doi: 10.1016/j.gde.2004.12.003 Bolstad BM, Irizarry RA, Åstrand M, Speed TP (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2): 185-193. doi: 10.1093/bioinformatics/19.2.185 Calimlioglu B, Karagoz K, Sevimoglu T, Kilic E, Gov E et al. (2015). Tissue-specific molecular biomarker signatures of type 2 diabetes: an integrative analysis of transcriptomics and proteinprotein interaction data. OMICS: A Journal of Integrative Biology 19 (9): 563-73. doi: 10.1089/omi.2015.0088 Casey T, Bond J, Tighe S, Hunter T, Lintault L et al. (2009). Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Research and Treatment 114 (1): 47-62. doi: 10.1007/s10549-008-9982-8
  3. Chen HJ, Huang RL, Liew PL, Su PH, Chen LY et al. (2018). GATA3 as a master regulator and therapeutic target in ovarian highgrade serous carcinoma stem cells. International Journal of Cancer 15143 (12): 3106-3119. doi: 10.1002/ijc.31750 Comertpay B, Gov E (2020). Identification of key biomolecules in rheumatoid arthritis through the reconstruction of comprehensive disease-specific biological networks. Journal of Autoimmunity 53 (3): 156-166. doi: 10.1080/08916934.2020.1722107 Croft D, O’Kelly G, Wu G, Haw R, Gillespie M et al. (2011). Reactome: a database of reaction